Summary
CVS Health Corporation (CVS) filed an 8-K on May 1, 2024, primarily to furnish a press release detailing their first-quarter 2024 financial results, which was issued on May 1, 2024, for the period ending March 31, 2024. While the filing itself does not contain the specific financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for a comprehensive overview of their performance. This standard practice indicates that the company is making its quarterly earnings publicly available in accordance with regulatory requirements. Investors seeking details on CVS Health's financial condition and operational results for the first quarter of 2024 should refer to the furnished press release. The 8-K filing serves as the official notification that these results have been released, and the press release itself contains the substantive financial data and management commentary. It's important to note that the information furnished in this 8-K is not considered "filed" for certain regulatory purposes, meaning it doesn't carry the same liabilities as a fully filed document under Section 18 of the Exchange Act.
Key Highlights
- 1CVS Health Corporation filed an 8-K on May 1, 2024, to announce Q1 2024 earnings.
- 2The 8-K filing primarily furnishes a press release dated May 1, 2024, as Exhibit 99.1.
- 3The press release contains the detailed results for the three months ended March 31, 2024.
- 4Investors need to consult the furnished press release (Exhibit 99.1) for specific financial and operational data.
- 5The filing confirms the release of Q1 2024 financial results as per standard SEC disclosure practices.
- 6Information furnished in this 8-K is not deemed 'filed' under Section 18 of the Exchange Act, limiting its regulatory liability.